Latest Buprenorphine Stories
DUBLIN and RALEIGH, N.C., May 14, 2015 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo International plc (NASDAQ: ENDP) (TSX: ENL), and BioDelivery Sciences International, Inc.
Harbor Village Detox comments on WLRN’s recent article on patients receiving addiction treatment when addiction is apparent in the ER. Miami, FL (PRWEB) May
RALEIGH, N.C., May 11, 2015 /PRNewswire/ -- BUNAVAIL(®) (buprenorphine and naloxone) buccal film showed a 25% average month-over-month growth in prescription sales over the quarter along
Developers of Clarity™ Intensive Outpatient Opiate Treatment Announce Undergraduate and Graduate Scholarships for Students of Evidence-Based Addiction Medicine West
Oral Buprenorphine Product Candidates (BuTab, REL-1028) to be Compared with Marketed Sublingual and Intravenous Formulations NEW YORK, April 21, 2015 /PRNewswire/ -- Relmada Therapeutics,
Phase 1 study to include additional cohorts with novel product candidate being developed for the treatment of neuropathic pain NEW YORK, April 16, 2015 /PRNewswire/ -- Relmada Therapeutics,
SALT LAKE CITY, April 8, 2015 /PRNewswire/ -- Phoenix PharmaLabs, Inc.
Programs encouraging appropriate use of painkillers could improve safety, reduce costs ST.
While many healthcare professionals continue to advocate in favor of methadone treatment for heroin addiction, a new survey reveals that half of Americans agree with Novus Medical Detox Center
Enteric-Coated Buprenorphine Product Candidates (BuTab, REL-1028) to be Compared with Marketed Intravenous and Sublingual Formulations NEW YORK, March 24, 2015 /PRNewswire/ -- Relmada
- A hairdresser.